Packaging of Omnitrope 10mg/1.5ml injectable solution.
Omnitrope 10mg15ml packaging

Injectable human growth hormone HGH

Omnitrope HGH

Omnitrope is a brand name for a synthetic form of human growth hormone (HGH) manufactured by Sandoz, a division of Novartis. It is a prescription medication used to treat various growth-related disorders in children and adults. Here’s a detailed description of Omnitrope:

  1. Composition: Omnitrope contains somatropin, which is a synthetic form of human growth hormone (hGH). Somatropin is identical to the naturally occurring growth hormone produced by the pituitary gland.
  1. Indications: Omnitrope is primarily prescribed for the treatment of growth hormone deficiency (GHD) in both children and adults. In children, GHD can lead to short stature and delayed growth, while in adults, it can manifest as decreased bone density, muscle mass, and overall quality of life.
  1. Administration: Omnitrope is typically administered via subcutaneous injection. The dosage and frequency of administration depend on the patient’s age, weight, and the condition being treated. It’s important for patients to receive proper training on how to self-administer the injections or have a caregiver who can assist them.
  1. Dosage: The dosage of Omnitrope varies depending on the individual’s needs and the condition being treated. For pediatric patients with growth hormone deficiency, the initial dosage is typically 0.16 to 0.24 mg/kg body weight per week, divided into daily injections. For adults with growth hormone deficiency, the recommended dosage is generally 0.15 to 0.3 mg/day, administered as a daily injection.
  1. Storage: Omnitrope should be stored at controlled room temperature between 2°C and 8°C (36°F and 46°F) before reconstitution. After reconstitution, the solution should be used immediately or refrigerated at 2°C to 8°C (36°F to 46°F) and used within 14 days. Care should be taken to avoid freezing or shaking the medication.
  1. Side Effects: Common side effects of Omnitrope may include injection site reactions (pain, redness, bruising), headaches, joint pain, muscle pain, swelling in the hands or feet, and numbness or tingling. More serious side effects such as allergic reactions, pancreatitis, and intracranial hypertension are rare but possible.
  1. Monitoring: Patients receiving Omnitrope therapy require regular monitoring by a healthcare professional to assess growth velocity (in pediatric patients), hormone levels, and potential side effects. Adjustments to dosage may be necessary based on these evaluations.
  1. Contraindications: Omnitrope should not be used in patients with active malignancy, diabetic retinopathy, acute critical illness, or hypersensitivity to somatropin or any of the ingredients in the formulation.
  1. Precautions: Special caution should be exercised when prescribing Omnitrope to patients with a history of intracranial lesions, diabetes mellitus, or other underlying medical conditions. Close monitoring of glucose levels is recommended in patients with diabetes.
  1. Cost and Insurance Coverage: Omnitrope can be expensive, and insurance coverage for growth hormone therapy may vary. Patients should consult with their healthcare provider and insurance company to determine coverage options and potential financial assistance programs.

Overall, Omnitrope is an important medication for the treatment of growth-related disorders, providing patients with improved growth, development, and quality of life when used under the guidance of a healthcare professional.

Packaging of Omnitrope 10mg/1.5ml injectable solution.
Omnitrope 10mg15ml packaging example for Vials Table


2-10mg Vials$1,360.00Total 30 IU
5-10mg Vials$3,060.00Total 150 IU
8-10mg Vials$4,780.00Total 240 IU
1-15mg Vials$1,060.00Total 45 IU
3-15mg Vials$2,760.00Total 135 IU
5-15mg Vials$4,310.00Total 225 IU

All the packages include overnight shipping

Buy Now